Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.16

+0.66 (1.23%)

as of Jun 5, 2026, 3:33:54 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

TOP PICK

Stock is down 10% on the announcement of the John Hancock deal. The deal itself will be 8/10% accretive in the first year. Trading at less than 10 X earnings, which make it a compelling buy.

WAIT

Their acquisition is very good, but the stock will be under some pressure because of the arbitrage and, after the deal closes, expect some US institutional shareholders may not have a mandate to hold Canadian stocks.

TOP PICK

The John Hancock acquisition was great. The weakness in the stock price makes it a good time to buy.

TOP PICK

Has dropped because of their purchase of John Hancock and you are getting it at less than 10 X earnings.

TOP PICK

Likes the acquisition of John Hancock in the US. Extremely well managed company. At a good price.

WAIT

The acquisition of John Hancock was a huge win for the long-term prospects. The stock will probably stall over the next 6 months.

BUY ON WEAKNESS

John Hancock acquisition was bought at a fair price. Synergies seem logical. Good management. US shareholders of John Hancock's will probably sell their shares which could give a real opportunity. Buy in the mid-$30.

BUY

Insurance sector is doing much better than earlier in the year. Looks attractive with their international exposure. Good yield. Solid balance sheet.

BUY

A core holding.

PAST TOP PICK

(Was a top pick June 12/03. Up 10%.) Still likes. Well positioned in their business in both the US and Asia. Disciplined management.

WEAK BUY

Insurance companies have been a little out of favor.Money has recently been moving out of banks and into insurance companies.Has had a move-up.Prefers Great West Life.Should do OK.

BUY

Expects a move into the mid $40's.Decent dividend.Expect a 10/12% return on a 1-year basis.

BUY

Well managed. Fair value in the short term, but expects it will have a price of $44 in 18 months. Stable.

BUY

Likes the international assets. Likes at $39.

HOLD

Strong and profitable. Looking for acquisitions and hopes that management is not too aggressive.

Showing 2,071 to 2,085 of 2,279 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)